Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

MYC Protein Expression, but Not High Grade Morphology, Is Associated with Poor Outcome in Non-Burkitt Diffuse Aggressive B-Cell Lymphomas: A SWOG S9704 Correlative Study

James R. Cook, MD, PhD, Bryan H. Goldman, MS, Raymond R. Tubbs, DO, Michael LeBlanc, PhD, Lisa M. Rimsza, MD, Patrick Stiff, MD, Richard I Fisher, MD

Blood (2012) 120 (21): 543.

https://doi.org/10.1182/blood.V120.21.543.543

Published: 2012

Journal Articles

Low Serum Vitamin D Levels Are Associated with Inferior Survival in Follicular Lymphoma: A Prospective Evaluation in SWOG and Lysa Studies.

Jennifer L. Kelly, PhD, MPH, Gilles Salles, MD, Bryan H. Goldman, MS, Richard I Fisher, MD, Olivier Casasnovas, Oliver W. Press, MD, PhD, David G. Maloney, MD, PhD, Pierre Soubeyran, Lisa M. Rimsza, MD, Michael LeBlanc, PhD, Herve Tilly, MD, Jonathan W. Friedberg, MD

Blood (2012) 120 (21): 2712.

https://doi.org/10.1182/blood.V120.21.2712.2712

Published: 2012

Journal Articles

Genetic Polymorphisms In Oxidative Stress-Related Genes Correlated with Outcome Following Anthracycline-Based Therapy for Aggressive B-Cell Non-Hodgkin Lymphomas

Heather L. Tardif, Song Yao, PhD, Bryan H. Goldman, MS, Catherine M. Spier, MD, Michael L. LeBlanc, PhD, Lisa M. Rimsza, MD, Daniel O. Persky, MD, Thomas P. Miller, MD, Richard I Fisher, MD, Christine B. Ambrosone, PhD, Margaret M. Briehl, PhD

Blood (2010) 116 (21): 321.

https://doi.org/10.1182/blood.V116.21.321.321

Published: 2010

Journal Articles

Fc Gamma Receptor 3a Genotype Predicts Overall Survival for Follicular Lymphoma Patients Treated On Southwest Oncology Group Trials with Combined Monoclonal Antibody Plus Chemotherapy but Not Chemotherapy Alone.

Daniel O. Persky, MD, David Dornan, Ph.D, Bryan H Goldman, MS, Rita M. Braziel, MD, Richard I Fisher, MD, Michael LeBlanc, PhD, David G. Maloney, MD, PhD, Thomas P. Miller, MD, Oliver W. Press, MD, PhD, Lisa M. Rimsza, MD

Blood (2009) 114 (22): 111.

https://doi.org/10.1182/blood.V114.22.111.111

Published: 2009

Journal Articles

MUM1 Expression in Follicular Lymphoma Is a Poor Prognostic Marker in Patients Treated with Immunochemotherapy (SWOG 9800/9911) but Not Chemotherapy Alone (SWOG 8809): A Southwest Oncology Group Correlative Science Study

Eric D Hsi, MD, Lisa Rimsza, MD, Bryan H Goldman, MS, James R. Cook, MD, PhD, Raymond R. Tubbs, DO, Oliver W. Press, MD, PhD, David G. Maloney, MD, PhD, Richard I Fisher, MD, John Sweetenham, MD

Blood (2008) 112 (11): 376.

https://doi.org/10.1182/blood.V112.11.376.376

Published: 2008

Journal Articles

Vorinostat (Suberoylanilide Hydroxamic Acid) in Relapsed or Refractory Hodgkin Lymphoma: SWOG 0517.

Mark H. Kirschbaum, MD, Bryan H. Goldman, MS, Jasmine M. Zain, MD, James R. Cook, MD, PhD, Lisa M. Rimsza, MD, Stephen J. Forman, MD, Richard I. Fisher, MD

Blood (2007) 110 (11): 2574.

https://doi.org/10.1182/blood.V110.11.2574.2574

Published: 2007

NARROW

MYC Protein Expression, but Not High Grade Morphology, Is Associated with Poor Outcome in Non-Burkitt Diffuse Aggressive B-Cell Lymphomas: A SWOG S9704 Correlative Study

Low Serum Vitamin D Levels Are Associated with Inferior Survival in Follicular Lymphoma: A Prospective Evaluation in SWOG and Lysa Studies.

Genetic Polymorphisms In Oxidative Stress-Related Genes Correlated with Outcome Following Anthracycline-Based Therapy for Aggressive B-Cell Non-Hodgkin Lymphomas

Fc Gamma Receptor 3a Genotype Predicts Overall Survival for Follicular Lymphoma Patients Treated On Southwest Oncology Group Trials with Combined Monoclonal Antibody Plus Chemotherapy but Not Chemotherapy Alone.

MUM1 Expression in Follicular Lymphoma Is a Poor Prognostic Marker in Patients Treated with Immunochemotherapy (SWOG 9800/9911) but Not Chemotherapy Alone (SWOG 8809): A Southwest Oncology Group Correlative Science Study

Vorinostat (Suberoylanilide Hydroxamic Acid) in Relapsed or Refractory Hodgkin Lymphoma: SWOG 0517.

Email alerts

ASH Publications

American Society of Hematology

MYC Protein Expression, but Not High Grade Morphology, Is Associated with Poor Outcome in Non-Burkitt Diffuse Aggressive B-Cell Lymphomas: A SWOG S9704 Correlative Study

Low Serum Vitamin D Levels Are Associated with Inferior Survival in Follicular Lymphoma: A Prospective Evaluation in SWOG and Lysa Studies.

Genetic Polymorphisms In Oxidative Stress-Related Genes Correlated with Outcome Following Anthracycline-Based Therapy for Aggressive B-Cell Non-Hodgkin Lymphomas

Fc Gamma Receptor 3a Genotype Predicts Overall Survival for Follicular Lymphoma Patients Treated On Southwest Oncology Group Trials with Combined Monoclonal Antibody Plus Chemotherapy but Not Chemotherapy Alone.

MUM1 Expression in Follicular Lymphoma Is a Poor Prognostic Marker in Patients Treated with Immunochemotherapy (SWOG 9800/9911) but Not Chemotherapy Alone (SWOG 8809): A Southwest Oncology Group Correlative Science Study

Vorinostat (Suberoylanilide Hydroxamic Acid) in Relapsed or Refractory Hodgkin Lymphoma: SWOG 0517.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only